PLANETS
27.1.2023 18:01:35 CET | Business Wire | Press release
Approximately 100,000 people from overseas visited teamLab Planets in Toyosu, Tokyo, between December 9, 2022 and January 9, 2023. (*1)
Of the visitors across one month, around 60% , or 1 in 2 visitors, were non-residents visiting Japan (*1), and the number of visitors from overseas has tripled compared to the same month in 2019 (before COVID-19).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230126005440/en/
teamLab, Floating in the Falling Universe of Flowers © teamLab
Furthermore, according to a survey conducted by the museum, about 70% of the visitors from overseas knew about the museum before considering their trip to Japan, and there was a trend of the museum being one of the main purposes to visit Tokyo. (*2)
*1 From the official website tickets purchaser data (survey period: December 9, 2022 - January 9, 2023)
*2 From the visitor survey data (survey period: December 17, 2022 - January 10, 2023)
We will continue to provide people around the world an experience based on teamLab Planets’ concept, “Immerse your Body, and with Others, Become One with the World”.
From Wednesday, March 1, 2023 to Sunday, April 30, 2023, two works, Floating in the Falling Universe of Flowers and Drawing on the Water Surface Created by the Dance of Koi and People - Infinity, will feature cherry blossoms that bloom across the space, on view during the spring season only.
Floating in the Falling Universe of Flowers, an artwork in which flowers bloom and change with the passage of time, and the universe of life spreads across the space, will be filled with cherry blossoms during this limited period. In the work Drawing on the Water Surface Created by the Dance of Koi and People - Infinity, visitors walk in water and koi swim on the surface of the infinitely expanding water. When the koi collide with people, they turn into cherry blossoms and scatter.
[Works that will feature cherry blossoms]
Floating in the Falling Universe of Flowers
teamLab, 2016-2018, Interactive Digital Installation, Endless, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/fitfuof/
Video: https://youtu.be/FzJ5svgIueQ
A seasonal year of flowers bloom and change with time, life spreads out into the universe.
Lie down or sit still in the space and eventually your body floats and you dissolve into the artwork.
Flowers grow, bud, bloom, and in time, the petals fall, and the flowers wither and die. The cycle of birth and death continues for perpetuity.
The artwork is not a pre-recorded image that is played back; it is created by a computer program that continuously renders the artwork in real time. As a whole, it is continuously changing, and previous visual states are never replicated. The universe at this moment in time can never be seen again.
Drawing on the Water Surface Created by the Dance of Koi and People - Infinity
teamLab, 2016-2018, Interactive Digital Installation, Endless, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/koi_and_people/
Video: https://youtu.be/SsRNptTOniw
Koi swim on the surface of water that stretches out into infinity. People can walk into the water.
The movement of the koi is influenced by the presence of people in the water and also other koi. When the fish collide with people they turn into flowers and scatter. Throughout the year, the flowers that bloom will change along with the seasons.
The trajectory of the koi is determined by the presence of people and these trajectories trace lines on the surface of the water.
The work is rendered in real time by a computer program. It is neither prerecorded nor on loop. The interaction between the viewer and the installation causes continuous change in the artwork. Previous visual states can never be replicated, and will never reoccur.
[Enjoy vegan ramen in an art space]
Vegan Ramen UZU Tokyo, a vegan ramen restaurant from Kyoto, opened in October 2021 on the same premises as teamLab Planets. Diners can enjoy ramen in teamLab’s Reversible Rotation - Non-Objective Space artwork space, as well as the Table of Sky and Fire and One Stroke Bench outside of the restaurant. Vegan Ramen UZU Tokyo also has vegan ice cream and various teas that are only available in Tokyo. The restaurant can be visited without entry to teamLab Planets.
Vegan Ramen UZU Tokyo: https://vegan-uzu.com/pages/uzu-tokyo
[teamLab Planets TOKYO]
teamLab, Floating Flower Garden; Flowers and I are of the Same Root, the Garden and I are One © teamLab
teamLab Planets is a museum where you walk through water, and a garden where you become one with the flowers. There are four massive exhibition spaces and two gardens.
By immersing your entire body with other people in these massive artworks, the boundary between the body and the artwork dissolves. The self, others, and the world become continuous, and we explore a new relationship without boundaries between ourselves and the world.
Enter barefoot, immerse your body with others in the artwork spaces, and become one with the world.
[Exhibition details]
teamLab Planets TOKYO
Location: teamLab Planets TOKYO, 6-1-16 Toyosu, Koto-ku, Tokyo
[Opening hours]
January - April
Monday - Friday 10:00 - 20:00
Saturdays, Sundays, and holidays 9:00 - 21:00
*March 20 (Mon), March 22 (Wed) - March 24 (Fri) 9:00 - 21:00
*March 25 (Sat) - April 2 (Sun) 9:00 - 22:00
*April 29 (Sat), April 30 (Sun) 9:00 - 22:00
*Last entry 1 hour before closing
[Closed]
February 9 (Thu), March 2 (Thu), April 13 (Thu)
*Opening hours are subject to change. Please check the official website for the latest details.
Official website: https://planets.teamlab.art/tokyo/
teamLab Planets Highlight Video: https://youtu.be/oiQoe9Ow9o0
*teamLab Planets will be open in Toyosu, Tokyo until the end of 2023.
[Tickets]
Adult: 3,200 JPY
Junior high and high school students: 2,000 JPY
Children (4 to 12 years old): 1,000 JPY
3 years old and under: Free
Disability discount: 1,600 JPY
*From Saturday, April 1, 2023: ticket prices for weekends, public holidays, and dates with extended opening hours will change to the prices below.
Adult: 3,500 JPY
Junior high and high school students: 2,300 JPY
Children (4 to 12 years old): 1,300 JPY
3 years old and under: Free
Disability discount: 1,900 JPY
teamLab Planets TOKYO DMM Ticket Store: https://teamlabplanets.dmm.com
[Measures to prevent the spread of COVID-19]
Please check the link below for details on the infection prevention measures implemented at teamLab Planets: https://teamlabplanets.dmm.com/covid-19
[Official HP/Social Media]
Official website: https://planets.teamlab.art/tokyo/
Instagram: https://www.instagram.com/teamlab.planets/
Facebook: https://www.facebook.com/TL.Planets/
Twitter: https://twitter.com/teamLabPlanets
#teamLabPlanets
[Food & Shop]
Vegan Ramen UZU Tokyo: https://vegan-uzu.com/pages/uzu-tokyo
teamLab Flower Shop & Art
*Please check the official website for opening hours
*Closed on the same days as teamLab Planets
[Measures to prevent the spread of COVID-19 (applicable to Food & Shop)]
・Implementation of regular cleaning and disinfection
・Seat disinfection after each customer
・Hand disinfection upon entry
・Restrictions on the number of people in the space
・Ensuring sufficient space between seats
・Employees wear masks
・Removal of tabletop items
・Temperature measurement
[Press kit]
https://goo.gl/tQXMLm
[PLANETS Co., Ltd.]
Established in 2017. Operates and manages the facilities of teamLab Planets TOKYO.
Location: Tokyo Nihonbashi Tower 10F, 2-7-1 Nihonbashi, Chuo-ku, Tokyo
Representative: Takumi Nomoto
[teamLab]
teamLab (f. 2001) is an international art collective. Their collaborative practice seeks to navigate the confluence of art, science, technology, and the natural world. Through art, the interdisciplinary group of specialists, including artists, programmers, engineers, CG animators, mathematicians, and architects, aims to explore the relationship between the self and the world, and new forms of perception.
In order to understand the world around them, people separate it into independent entities with perceived boundaries between them. teamLab seeks to transcend these boundaries in our perceptions of the world, of the relationship between the self and the world, and of the continuity of time. Everything exists in a long, fragile yet miraculous, borderless continuity.
teamLab exhibitions have been held in cities worldwide, including New York, London, Paris, Singapore, Silicon Valley, Beijing, and Melbourne among others. teamLab museums and large-scale permanent exhibitions include teamLab Borderless and teamLab Planets in Tokyo, teamLab Borderless Shanghai, teamLab SuperNature Macao, and teamLab Massless Beijing, with more to open in cities including Abu Dhabi, Hamburg, Jeddah, and Utrecht.
teamLab’s works are in the permanent collection of the Museum of Contemporary Art, Los Angeles; Art Gallery of New South Wales, Sydney; Art Gallery of South Australia, Adelaide; Asian Art Museum, San Francisco; Asia Society Museum, New York; Borusan Contemporary Art Collection, Istanbul; National Gallery of Victoria, Melbourne; and Amos Rex, Helsinki.
Website: https://www.teamlab.art/
Instagram: https://instagram.com/teamlab/
Facebook: https://www.facebook.com/teamLab.inc
Twitter: https://twitter.com/teamLab_net
YouTube: https://www.youtube.com/c/teamLabART
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230126005440/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
